# Predicting Effective Therapy in Pancreatic Cancer

> **NCT03033927** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 74 (actual)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** CTC isolocation and analysis

## Key facts

- **NCT ID:** NCT03033927
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-01-24
- **Primary completion:** 2027-01-24
- **Final completion:** 2027-01-24
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033927, "Predicting Effective Therapy in Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03033927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*